Loading…
Lobbying Spend
—
Filings
48
Firms Hired
1
Active Period
2015–2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Lainie Jones Comprehensive Cancer Survivorship Act of 2026
2026 · third_quarter · Firm: I STREET ADVOCATES
S. 705, The Innovation in Pediatric Drugs Act; Medicaid coverage for pediatric cancer, HR 8839, The Lainie Jones Comprehensive Cancer Survivorship Act; S.4717, The Asal Sayas National Strategy on Young Adult Cancers Act
Client expense: — · Firm income: $10,000
Matched citations: HR 8839
Asal Sayas National Strategy on Young Adult Cancers Act
2026 · third_quarter · Firm: I STREET ADVOCATES
S. 705, The Innovation in Pediatric Drugs Act; Medicaid coverage for pediatric cancer, HR 8839, The Lainie Jones Comprehensive Cancer Survivorship Act; S.4717, The Asal Sayas National Strategy on Young Adult Cancers Act
Client expense: — · Firm income: $10,000
Matched citations: S.4717
Innovation in Pediatric Drugs Act of 2025
2026 · third_quarter · Firm: I STREET ADVOCATES
S. 705, The Innovation in Pediatric Drugs Act; Medicaid coverage for pediatric cancer, HR 8839, The Lainie Jones Comprehensive Cancer Survivorship Act; S.4717, The Asal Sayas National Strategy on Young Adult Cancers Act
Client expense: — · Firm income: $10,000
Matched citations: S. 705
Lainie Jones Comprehensive Cancer Survivorship Act of 2026
2026 · second_quarter · Firm: I STREET ADVOCATES
S. 705, The Innovation in Pediatric Drugs Act; survivorship in pediatric cancer, Medicaid coverage for pediatric cancer, HR 8839, The Lainie Jones Comprehensive Cancer Survivorship Act
Client expense: — · Firm income: $10,000
Matched citations: HR 8839
Innovation in Pediatric Drugs Act of 2025
2026 · second_quarter · Firm: I STREET ADVOCATES
S. 705, The Innovation in Pediatric Drugs Act; survivorship in pediatric cancer, Medicaid coverage for pediatric cancer, HR 8839, The Lainie Jones Comprehensive Cancer Survivorship Act
Client expense: — · Firm income: $10,000
Matched citations: S. 705
Innovation in Pediatric Drugs Act of 2025
2026 · first_quarter · Firm: I STREET ADVOCATES
S. 705, The Innovation in Pediatric Drugs Act; survivorship in pediatric cancer, Medicaid coverage for pediatric cancer
Client expense: — · Firm income: $10,000
Matched citations: S. 705
Innovation in Pediatric Drugs Act of 2025
2025 · fourth_quarter · Firm: I STREET ADVOCATES
S. 705, The Innovation in Pediatric Drugs Act; survivorship in pediatric cancer, Medicaid coverage for pediatric cancer
Client expense: — · Firm income: $10,000
Matched citations: S. 705
Innovation in Pediatric Drugs Act of 2025
2025 · third_quarter · Firm: I STREET ADVOCATES
S. 705, The Innovation in Pediatric Drugs Act; survivorship in pediatric cancer, Medicaid coverage for pediatric cancer
Client expense: — · Firm income: $10,000
Matched citations: S. 705
Innovation in Pediatric Drugs Act of 2025
2025 · second_quarter · Firm: I STREET ADVOCATES
S. 705, The Innovation in Pediatric Drugs Act; survivorship in pediatric cancer, Medicaid coverage for pediatric cancer
Client expense: — · Firm income: $10,000
Matched citations: S. 705
Innovation in Pediatric Drugs Act of 2025
2025 · first_quarter · Firm: I STREET ADVOCATES
S. 705, The Innovation in Pediatric Drugs Act; survivorship in pediatric cancer, Medicaid coverage for pediatric cancer
Client expense: — · Firm income: $10,000
Matched citations: S. 705
Comprehensive Cancer Survivorship Act
2024 · fourth_quarter · Firm: I STREET ADVOCATES
Support for the Comprehensive Cancer Survivorship Act (HR 4363/S 2213); appropriations for survivorship and pediatric cancer drug development; legislation to promote increased childhood cancer therapies - Innovation in Pediatric Drugs Act (HR 6664/S. 4905)
Client expense: — · Firm income: $10,000
Matched citations: HR 4363
Innovation in Pediatric Drugs Act of 2023
2024 · fourth_quarter · Firm: I STREET ADVOCATES
Support for the Comprehensive Cancer Survivorship Act (HR 4363/S 2213); appropriations for survivorship and pediatric cancer drug development; legislation to promote increased childhood cancer therapies - Innovation in Pediatric Drugs Act (HR 6664/S. 4905)
Client expense: — · Firm income: $10,000
Matched citations: HR 6664
Comprehensive Cancer Survivorship Act
2024 · fourth_quarter · Firm: I STREET ADVOCATES
Support for the Comprehensive Cancer Survivorship Act (HR 4363/S 2213); appropriations for survivorship and pediatric cancer drug development; legislation to promote increased childhood cancer therapies - Innovation in Pediatric Drugs Act (HR 6664/S. 4905)
Client expense: — · Firm income: $10,000
Matched citations: S 2213
Innovation in Pediatric Drugs Act of 2024
2024 · fourth_quarter · Firm: I STREET ADVOCATES
Support for the Comprehensive Cancer Survivorship Act (HR 4363/S 2213); appropriations for survivorship and pediatric cancer drug development; legislation to promote increased childhood cancer therapies - Innovation in Pediatric Drugs Act (HR 6664/S. 4905)
Client expense: — · Firm income: $10,000
Matched citations: S. 4905
Comprehensive Cancer Survivorship Act
2024 · third_quarter · Firm: I STREET ADVOCATES
Support for the Comprehensive Cancer Survivorship Act (HR 4363/S 2213); appropriations for survivorship and pediatric cancer drug development; legislation to promote increased childhood cancer therapies - Innovation in Pediatric Drugs Act (HR 6664/S. 4905)
Client expense: — · Firm income: $10,000
Matched citations: HR 4363
Innovation in Pediatric Drugs Act of 2023
2024 · third_quarter · Firm: I STREET ADVOCATES
Support for the Comprehensive Cancer Survivorship Act (HR 4363/S 2213); appropriations for survivorship and pediatric cancer drug development; legislation to promote increased childhood cancer therapies - Innovation in Pediatric Drugs Act (HR 6664/S. 4905)
Client expense: — · Firm income: $10,000
Matched citations: HR 6664
Comprehensive Cancer Survivorship Act
2024 · third_quarter · Firm: I STREET ADVOCATES
Support for the Comprehensive Cancer Survivorship Act (HR 4363/S 2213); appropriations for survivorship and pediatric cancer drug development; legislation to promote increased childhood cancer therapies - Innovation in Pediatric Drugs Act (HR 6664/S. 4905)
Client expense: — · Firm income: $10,000
Matched citations: S 2213
Innovation in Pediatric Drugs Act of 2024
2024 · third_quarter · Firm: I STREET ADVOCATES
Support for the Comprehensive Cancer Survivorship Act (HR 4363/S 2213); appropriations for survivorship and pediatric cancer drug development; legislation to promote increased childhood cancer therapies - Innovation in Pediatric Drugs Act (HR 6664/S. 4905)
Client expense: — · Firm income: $10,000
Matched citations: S. 4905
Comprehensive Cancer Survivorship Act
2024 · second_quarter · Firm: I STREET ADVOCATES
Support for the Comprehensive Cancer Survivorship Act (HR 4363/S 2213); appropriations for survivorship and pediatric cancer drug development; legislation to promote increased childhood cancer therapies - Innovation in Pediatric Drugs Act (HR 6664)
Client expense: — · Firm income: $10,000
Matched citations: HR 4363
Innovation in Pediatric Drugs Act of 2023
2024 · second_quarter · Firm: I STREET ADVOCATES
Support for the Comprehensive Cancer Survivorship Act (HR 4363/S 2213); appropriations for survivorship and pediatric cancer drug development; legislation to promote increased childhood cancer therapies - Innovation in Pediatric Drugs Act (HR 6664)
Client expense: — · Firm income: $10,000
Matched citations: HR 6664
Comprehensive Cancer Survivorship Act
2024 · second_quarter · Firm: I STREET ADVOCATES
Support for the Comprehensive Cancer Survivorship Act (HR 4363/S 2213); appropriations for survivorship and pediatric cancer drug development; legislation to promote increased childhood cancer therapies - Innovation in Pediatric Drugs Act (HR 6664)
Client expense: — · Firm income: $10,000
Matched citations: S 2213
Comprehensive Cancer Survivorship Act
2024 · first_quarter · Firm: I STREET ADVOCATES
Support for the Comprehensive Cancer Survivorship Act (HR 4363/S 2213); appropriations for survivorship and pediatric cancer drug development; legislation to promote increased childhood cancer therapies - Innovation in Pediatric Drugs Act (HR 6664)
Client expense: — · Firm income: $10,000
Matched citations: HR 4363
Innovation in Pediatric Drugs Act of 2023
2024 · first_quarter · Firm: I STREET ADVOCATES
Support for the Comprehensive Cancer Survivorship Act (HR 4363/S 2213); appropriations for survivorship and pediatric cancer drug development; legislation to promote increased childhood cancer therapies - Innovation in Pediatric Drugs Act (HR 6664)
Client expense: — · Firm income: $10,000
Matched citations: HR 6664
Comprehensive Cancer Survivorship Act
2024 · first_quarter · Firm: I STREET ADVOCATES
Support for the Comprehensive Cancer Survivorship Act (HR 4363/S 2213); appropriations for survivorship and pediatric cancer drug development; legislation to promote increased childhood cancer therapies - Innovation in Pediatric Drugs Act (HR 6664)
Client expense: — · Firm income: $10,000
Matched citations: S 2213
Comprehensive Cancer Survivorship Act
2023 · fourth_quarter · Firm: I STREET ADVOCATES
Reintroduction of the Comprehensive Cancer Survivorship Act (HR 4363/S 2213); appropriations for survivorship and pediatric cancer drug development; legislation to promote increased childhood cancer therapies - Innovation in Pediatric Drugs Act (HR 6664)
Client expense: — · Firm income: $10,000
Matched citations: HR 4363
Source: Senate LDA